Latest Operating Expenses News

Page 19 of 106
AoFrio’s revenue fell 21.5% in 1H26, dragged down by a 50.5% plunge in motor sales due to US tariffs, while IoT revenue grew modestly. The company launched new cellular and software platforms, raised NZD 8.9 million, and is expanding into Food Retail, but full-year revenue growth now looks unlikely.
Sophie Babbage
Sophie Babbage
5 Aug 2026
Vitrafy Life Sciences reported an 80% revenue surge and halved its net loss, buoyed by US military validation and major blood network partnerships. A $32 million capital raise fuels its US commercial expansion and manufacturing scale-up.
Victor Sage
Victor Sage
4 Aug 2026
Singular Health deepens US healthcare foothold with ongoing Triple-S contract talks, PNS licence expansion, and Miami-Dade educational rollout, supported by a solid $10.1 million cash reserve.
Victor Sage
Victor Sage
31 July 2026
Neurotech International has secured FDA clearance for its NTI164 Investigational New Drug application and obtained Notices of Allowance for two US patents, advancing its Phase 3 autism spectrum disorder program.
Ada Torres
Ada Torres
31 July 2026
Acrux Limited’s FY26 receipts soared 960% to $5 million, fuelled by licensing milestones and growing generic sales, while FDA guidance clears the way for pivotal Phase III trials of its Female Testosterone therapy.
Victor Sage
Victor Sage
31 July 2026
Decidr AI Industries accelerated its commercial growth with a 71% jump in annualised exit-rate revenue to $13.6 million and bolstered its cash position to $23.4 million following a $14.2 million equity raise.
Sophie Babbage
Sophie Babbage
31 July 2026
archTIS surged to a record FY2026 with Annual Recurring Revenue hitting $14.8 million, driven by major US and Australian Defence wins and expanding its customer base beyond defence.
Sophie Babbage
Sophie Babbage
31 July 2026
Tissue Repair advances its US Phase III chronic wound trial with 100 patients randomised and targets October FDA 510(k) submission. The company reports a robust cash position bolstered by R&D refunds and has cut manufacturing scale-up costs.
Ada Torres
Ada Torres
31 July 2026
Enlitic slashed its net operating cash outflow by 76% in Q2 FY26 and secured binding commitments for a A$15 million conditional placement alongside convertible note conversions, positioning the company with a pro forma cash balance of about A$18 million and a debt-free balance sheet.
Victor Sage
Victor Sage
31 July 2026
Omni Bridgeway delivered a standout FY26 with record investment proceeds and new commitments, underpinned by disciplined cost management and a robust pipeline.
Claire Turing
Claire Turing
31 July 2026
Resouro Strategic Metals has filed a comprehensive NI 43-101 Technical Report that underpins its Preliminary Economic Assessment for the Tiros Titanium and Rare Earths Project in Brazil, confirming robust economics and a capital-efficient staged development strategy.
Maxwell Dee
Maxwell Dee
30 July 2026
BetMakers Technology Group delivered a robust Q4 FY26 with revenue rising 9.4% to $24.2 million and adjusted EBITDA nearly doubling to $4.5 million, driven by new commercial deals and operational efficiencies.
Sophie Babbage
Sophie Babbage
30 July 2026

Browse the archive

Full archive